Table 3.
Applied | Theoretical | Total | |
---|---|---|---|
Pertinent to clinical trials | 16% (31) | 4% (11) | 42 |
Not pertinent to clinical trials | 84% (164) | 96% (264) | 428 |
Total | 195 | 275 | 470 |
Applied | Theoretical | Total | |
---|---|---|---|
Pertinent to clinical trials | 16% (31) | 4% (11) | 42 |
Not pertinent to clinical trials | 84% (164) | 96% (264) | 428 |
Total | 195 | 275 | 470 |